These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 838141)

  • 1. The encephalitogenicity of the Hempt vaccine.
    Nyerges G; Jaszovszky S; Pintér A; Hompó Z
    Dev Biol Stand; 1977; 34():165-8. PubMed ID: 838141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The allergic-reactive and encephalitogenic potential of rabies vaccines prepared from different virulent materials].
    Serban O; Toacsen E; Ionescu T; Potorac E; Anghelescu N; Bunea M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(2):97-107. PubMed ID: 6128780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory techniques in rabies: test for neuroallergenic activity.
    Gispen R
    Monogr Ser World Health Organ; 1973; (23):295-6. PubMed ID: 4219498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side-effects of inoculation with the Hempt vaccine (rabies vaccine) in childhood].
    Doutlík S; Vacek Z; Harvánková D
    Cesk Pediatr; 1972 Feb; 27(2):72-3. PubMed ID: 4400907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trials on the antigenicity, protectivity and encephalitogenicity of the Hempt vaccine and considerations on rabies protective vaccination in Germany].
    Kuwert E
    Arch Hyg Bakteriol; 1967 May; 151(1):130-45. PubMed ID: 4386311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroallergic activity of anti-rabies vaccines].
    Augustinský V; Svrcek S; Vrtiak OJ; Benko G; Konrád V
    Vet Med (Praha); 1981 Jun; 26(6):353-65. PubMed ID: 6791368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory investigations on neuroparalytic accidents associated to suckling mouse brain rabies vaccine. II.--Encephalitogenicity of murine brain myelin preparations.
    Varela'Diaz VM; Imas B; Soto E; Larghi OP; Cuba-Caparó A; Fuenzalida E
    Ann Immunol (Paris); 1974 Nov; 125(6):925-38. PubMed ID: 4143100
    [No Abstract]   [Full Text] [Related]  

  • 9. Freeing rabies virus of the neuroallergenic factor from brain tissue.
    Karakuyumchan MK; Nadaichik LV; Pille ER; Rozina EE
    Acta Virol; 1981 May; 25(3):155-8. PubMed ID: 6115564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological complications due to Semple-type antirabies vaccine. Clinical and therapeutic aspects.
    Swamy HS; Anisya V; Nandi SS; Kaliaperumal VG
    J Assoc Physicians India; 1991 Sep; 39(9):667-9. PubMed ID: 1667658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhesus diploid rabies vaccine (adsorbed): neurological safety in guinea pigs and Lewis rats.
    Levenbook IS; Elisberg BL; Driscoll BF
    Vaccine; 1986 Dec; 4(4):225-7. PubMed ID: 2432737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semple rabies vaccine: presence of myelin basic protein and proteolipid protein and its activity in experimental allergic encephalomyelitis.
    Javier RS; Kunishita T; Koike F; Tabira T
    J Neurol Sci; 1989 Nov; 93(2-3):221-30. PubMed ID: 2480399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG-changes during preventive rabies therapy using the Hempt-vaccine].
    Lafrenz M; Külz J
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1165-6. PubMed ID: 240124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe remaining damage following rabies vaccination with Hempt vaccine].
    Bohlmann HG
    Med Klin; 1968 Nov; 63(48):1932-4. PubMed ID: 4387916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sensitivity against brain tissue in patients immunized with the Hempt vaccine].
    Doutlík S; Vacek Z; Jezková Z; Vepreková A; Kyselová M; Pekárek J; Srámková L; Harvánková D
    Dtsch Gesundheitsw; 1972 Jul; 27(27):1263-6. PubMed ID: 5075400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe neurological complications after vaccination with Semple's rabies vaccine].
    Granicki O; Dorant-Wilczek Z; Głowacka J; Lempicka A
    Pol Tyg Lek; 1986 Jan; 41(3):78-80. PubMed ID: 3703728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory investigations of neuroparalytic accidents associated with suckling mouse brain rabies vaccine. I.--Encephalitogenicity and virological studies.
    Trejos A; Lewis V; Fuenzalida E; Larghi OP
    Ann Immunol (Paris); 1974 Nov; 125(6):917-24. PubMed ID: 4157004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications after antirabies treatment using the Hempt-vaccine].
    Lafrenz M
    Z Gesamte Inn Med; 1975 Jun; 30(12):419-23. PubMed ID: 1199265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.